Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 385.00p 370.00p 400.00p 385.00p 385.00p 385.00p 56,265 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 21.9 260

Eco Animal Health Share Discussion Threads

Showing 1026 to 1050 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
09/8/2019
13:18
Cerrito - think you have just been a tad unlucky. ASF is behind the weakness. Just to firm up on the Chinese numbers, they are not quite as significant as you think. China makes c£4m net profit per annum, but the impact on the group is only £2m as there is a 52% minority interest. See pages 80 and 93. Provided ASF doesn’t move around the world, other territories should be fairly buoyant and are wholly owned so pound for pound, twice as valuable.
topvest
09/8/2019
12:42
Yes, taken a look myself. ASF could well lead to further downgrades this year, and presumably things will take a while to recover. https://www.cnbc.com/2019/08/09/china-inflation-july-2019-producer-prices-ppi-and-consumer-price-index-cpi.html In the end, China will no doubt bounce back. £5 is probably fair value here. If you look at the value in use numbers in note 11 there is c£168m to £287m of headroom by my reckoning.
topvest
07/8/2019
08:28
Insightful post. share price doesn't like it though! The other difficult aspect to gauge is how much incremental sales they will secure from all the recent (last 2 years) approvals, especially egg laying hens which is big business. There must be still good opportunity for further growth through continued new approvals of aivlosin. Diversification though is key for longer-term sustainability.
audigger
06/8/2019
16:46
I have gone through the annual report. Given ASF I feel I am flying blind here. I have no idea as to how much revenue and profit(however defined) comes from pigs as compared to poultry,cattle etcet. I can get nothing from the media as to what is happening in China with ASF; there are stories of it being in neighbouring countries to China and very recent outbreaks in Bulgaria and Romania and the concern it may go into Germany etcet. Luckily it does not appear to have made its way to the Americas. I hope I can make the AGM to get some clarity here. To get an idea of the importance of China remember that in 17/18 Far East(and I assume that China is the biggest contributor here) produced £14m out of the £22m adjusted ebitda. Also note per page 14 of the AR, that Chinese subsidary’s reported operating profit fell between the years from £6.4m to £5.2m. Difficult to know how this figure compares with total Group Profit from operations which went up from £14.1m to £14.7m. Page 85 tells us that of the £29.5m trade receivables at FYE, £9m were in RMB-though that high percentage would have been distorted because of extended credit terms in China. Finally page 97 shows that last year profits were more sensitive to a change in RMB FX rate than US$ rate(which makes sense given that they are both importing and exporting in US$) with a 10% change in the RMB/£ rate impacting profit by £788k. For me the upshot of these random figures is that we need to have a good handle of what is happening in China given its importance to EAH. I am going on the basis that the share price will wait to see how effective the development expenditure which will go from £3.7m in 17/18, to £5.3m in 18/19 and to £9m in 19/20 given that it will not feed through to sales till 22/23. For me good that wanting to diversify away from aivlosin. Interesting that they have £10m+of UK tax losses which no doubt will increase given r&d expenditure. Be interesting to know how they are going to deal with this situation, Also interesting to see the change in shareholder composition between June 18 and June 19. EAH has important institutional backing-institutions with 3%+ are approx. 60% of shareholding as of June 19 which added to the 10% held by the Lawrence family suggests why there is a wide trading margin. Merian/Old Mutual have gone from 8% to 4% and Schroder from 11% to 7% and we seem to have said hello to Blackrock with 4%. I find their treatment of administrative expenses frustrating-they were £7m in H1 and £12m in H1 and H2 18/19 FY and not clear why they rose between the halves; for 17/18 the July 2 2018 prelims announcement had them as £18.5m and then in the December 10 2018 Interims RNS said that 17/18m admin expenses were £13.4m which does not improve one’s mood. The truth is that I have messed up here as I have an average in price of £4.85 and difficult to see it getting back there any time soon. I hope I can make the AGM.
cerrito
01/8/2019
16:50
Encouraging to see that someone is confident enough to have bought 200,000 shares this morning.
aimingupward2
01/8/2019
14:50
September Annual general meeting
waldron
01/8/2019
11:35
EAH Peel Hunt Buy 600.00 - Reiterates
maywillow
17/7/2019
11:45
Well its taking a hit today!
audigger
03/7/2019
07:43
EAH Peel Hunt Buy 600.0 Reiterates CVSG Peel Hunt Buy 775.00 - Reiterates
grupo
19/6/2019
12:25
Yes, results OK. Happy to hold. Just making the observation that the directors obviously thought £6 was expensive, given the various sales. Will take a year or two to get back to £6. We are probably stuck more in a £3-5 range for a while, until the normal tailwind of growth in China and elsewhere resumes. Easy to say with hindsight, but £6 was a sell. Probably about fair value at £4 at the moment.
topvest
19/6/2019
10:52
Duncan Ferris Sharecast News 19 Jun, 2019 10:30 Eco Animal Health profits jump but China sales flat amid swine flu outbreak pig,swine,pork,bacon,animal, farm Eco Animal Health Group on Wednesday reported double-digit annual profit and revenue growth, but said the outbreak of African Swine Fever (ASF) in China and trade conflict between the Washington and Beijing kept a lid on growth. ECO Animal Health Group 3.72 19/06/1911:06:03 8.14% 0.20 FTSE AIM All-Share 934.84 09:50 19/06/19 -0.35% -3.25 FTSE AIM 100 4,885.08 09:50 19/06/19 -0.51% -24.96 The animal-focused pharmaceuticals company returned a profit before tax of £15.2m for the year ended 31 March, for an increase of 10% when compared to the year before, with revenue coming in 11% higher at £74.6m as the company generated sales in more than seventy countries. Sales were flat in China as the nation lost an estimated 200m pigs, or 30% of its swine production, to ASF, leading the AIM traded company to shift its focus in the country to include poultry from being almost exclusively directed at the pig sector. Worldwide sales of pig and poultry disease treatment Aivlosin increased by 14% and accounted for 78% of total revenue, while sales of the smaller Ecomectin anti-parasitic range dropped by 7% amid European manufacturing issues and altered distribution purchasing patterns. Sales of all other products rose by 6% after being driven by increased sales in Mexico, while strong overall sales growth was evident in North America, Latin America, Thailand and India. Marc Loomes, chief executive of Eco, said: "These are credible results for a year that was adversely depressed by both ASF and a trade war between the USA and China, our two largest markets. We are confident that our accelerated development programmes in vaccines and other products will add long term growth. For the year ahead we expect to report continued growth and to perform in line with the board’s expectations." Eco Animal Health Group's shares were up 5.97% at 373.00p at 0938 BST.
waldron
19/6/2019
08:38
I was expecting worse. This shows a degree of resilience to some significant challenge.
audigger
19/6/2019
08:31
Share price up a tad, so results seem to be slightly better than expected. Below original market consensus of 20.3p though. Standing back from it, EAH seem to have lost a couple of years in terms of profitability growth. 20p EPS not achieved last year or the year before. Maybe 2019/20 then. That's the reason why the share price has declined, and why the main insiders sold a few years back in volume.
topvest
19/6/2019
08:25
EAH Peel Hunt Buy 600.00 Reiterates
the grumpy old men
19/6/2019
08:17
I share your sentiment battlebus2. I see they had a stronger H2 than H1 with sales up from £32m to £43m in H2 and adjusted ebitda up from £8.6m to £11.4m but will need to do more analysis before drawing up a firm conclusion. Sales to China and Japan up from £27.6m to £28.2m but they did not give us a geographical breakdown for H1 so we are not told exactly how H2 China sales fared. I see in note 10 a big increase in RMB receivables but I assume that reflects a change in policy in currency invoicing.
cerrito
19/6/2019
08:02
Thought they were better than I’d hoped for.
battlebus2
19/6/2019
07:52
Results a tad disappointing for the second year in a row. As ever, it appears that the market was aware of this in advance. Oh well, still a growth company. Will continue to hold for a better year. Hopefully, they will out-perform again soon.
topvest
31/5/2019
17:27
You are correct spooky that directors have over the last year sold the shares they have been granted in options but not in my view of a scale to depress the price. It may well be that they have family financial commitments The reason I am not buying more is I do not know the impact that ASF has on their business. No doubt they are enjoying the current exchange rate
cerrito
28/5/2019
21:36
Directors dealing are only part of the story
erogenous jones
28/5/2019
20:35
Directors have been falling over themselves to sell stock for the last three years, might be worth waiting until that shows some signs of changing IMO.
spooky
28/5/2019
20:32
Dipped my toe in today to test the water. Looks like a decent entry point. I like to average up. Doubt I will contribute much to the thread.
erogenous jones
27/5/2019
07:28
Http://investing.thisismoney.co.uk/broker-views/index/date/27-05-2019 Eco Animal Health Group PLC EAH Peel Hunt Buy 370.00 370.00 725.00 - Reiterates NO CHANGE STILL APEELING SUCH CONFIDENCE
grupo
23/5/2019
18:24
Chill..it will no doubt bounce when it’s ready.
topvest
23/5/2019
13:57
I am assuming this drop is due to African Swine Fever, but who knows
cerrito
21/5/2019
10:08
It continues. And interims are some way off so a while until we get a financial update. Some director buys at these bargain prices would be most welcome!
audigger
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190821 03:24:11